<?xml version="1.0" encoding="UTF-8"?>
<p>HMPV infection is associated with a broad spectrum of clinical signs in patients of all age groups, and is the cause of upper and lower respiratory tract infection in infants and young children [
 <xref ref-type="bibr" rid="CR30">30</xref>]. It is second only to RSV as a significant cause of bronchiolitis in early childhood and children are most likely to be hospitalised with severe disease. Studies have linked HMPV with acute otitis media and asthma exacerbations in children and with exacerbations of both asthma and chronic obstructive pulmonary disease (COPD) in adults. However, severe disease may occur in all patients with underlying medical conditions such as cardiopulmonary disease, the elderly and immunocompromised subjects. In these subjects the virus can cause prolonged and serious infections, particularly severe lung disease including fatality [
 <xref ref-type="bibr" rid="CR10">10</xref>] (Fig. 
 <xref rid="Fig3" ref-type="fig">5.3</xref>). 
</p>
